SNO 2018: The Dopamine Receptor D2 Antagonist ONC201 Appears to Exhibit Clinical Activity in Some Patients With H3 K27M-Mutant Glioma
Updated clinical data continue to support this novel agent.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.